Analyst firms · Morgan Stanley · NVST
Morgan Stanley NVST price target and rating history
Envista Holdings Corporation (NVST) · Health Care
Morgan Stanley rates Envista Holdings Corporation (NVST) Equal-Weight with a $21 price target, as of its latest action on Apr 26, 2024. It has published 4 rating actions on NVST since January 2022, including 1 upgrade and 1 downgrade. Across 5 firms with a NVST price target in the last 12 months, the median target is $27.
- Current rating
- Equal-Weight
- Price target
- $21
- Median target, all firms
- $27
- Actions on NVST
- 4
Morgan Stanley price target on NVST
Every Morgan Stanley rating on NVST
- Apr 26, 2024
- Feb 10, 2022
- Jan 31, 2022
- Jan 7, 2022
How other firms rate NVST
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Robert W. Baird | Neutral | $26 | Oct 15, 2026 |
| BMO Capital Markets | Market Perform | $27 | Jul 9, 2026 |
| Citigroup | Neutral | $29 | Apr 15, 2026 |
| Leerink Partners | Outperform | $35 | Feb 6, 2026 |
| Barclays | Overweight | $24 | Dec 9, 2025 |
Questions about Morgan Stanley and NVST
- What is Morgan Stanley's price target for NVST?
- Morgan Stanley's latest stated price target for Envista Holdings Corporation (NVST) is $21, from its action on Apr 26, 2024.
- What is Morgan Stanley's rating on NVST?
- Morgan Stanley rates NVST Equal-Weight, a neutral rating, as of Apr 26, 2024.
- When did Morgan Stanley last change its view on NVST?
- On Apr 26, 2024, Morgan Stanley downgrades to Equal-Weight from Overweight, price target $33 to $21.
- How does Morgan Stanley's NVST target compare with other analysts?
- Across 5 firms with a NVST price target in the last 12 months, the median target is $27.
More NVST rating histories
All Morgan Stanley ratingsNVST news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.